DexCom (DXCM) operating expenses was $1.9B in FY2025 (+3% YoY). The tables below show the complete quarterly and annual operating expenses history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Operating Expenses
Fiscal Year
Operating Expenses
YoY
2025
$1.9B
+3%
2024
$1.8B
+9%
2023
$1.7B
+13%
2022
$1.5B
+5%
2021
$1.4B
+44%
2020
$981M
+26%
2019
$781M
-8%
2018
$850M
+59%
2017
$535M
+21%
2016
$442M
+32%
2015
$336M
+70%
2014
$198M
+53%
2013
$129M
+26%
2012
$102M
+27%
2011
$81M
+27%
2010
$64M
+28%
2009
$50M
Recent Quarterly Operating Expenses
Quarter
Operating Expenses
Q1 2026
$495M
Q4 2025
$470M
Q3 2025
$489M
Q2 2025
$476M
Q1 2025
$455M
Q4 2024
$467M
Q3 2024
$442M
Q2 2024
$469M
Q1 2024
$461M
Q4 2023
$440M
Q3 2023
$418M
Q2 2023
$418M
Source: DXCM on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.